Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Ciclopirox by ATLAS Molecular Pharma for Porphyria (Erythropoietic Protoporphyri): Likelihood of Approval
Ciclopirox is under clinical development by ATLAS Molecular Pharma and currently in Phase I for Porphyria (Erythropoietic Protoporphyri). According to...
Data Insights
Ciclopirox by ATLAS Molecular Pharma for Porphyria (Erythropoietic Protoporphyri): Likelihood of Approval
Ciclopirox is under clinical development by ATLAS Molecular Pharma and currently in Phase I for Porphyria (Erythropoietic Protoporphyri). According to...